Ten-year experience in atenolol use and exercise evaluation in children with genetically proven long QT syndrome

BACKGROUND: Due to its availability, atenolol is the primary beta-blocker used in Australia for children with long QT syndrome. There is limited data on long-term follow-up of its use. METHODS: A single-tertiary-center, retrospective, observational study investigating all children and adolescents wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwok, Sit-Yee, Pflaumer, Andreas, Pantaleo, Sarah-Jane, Date, Erin, Jadhav, Mangesh, Davis, Andrew Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728996/
https://www.ncbi.nlm.nih.gov/pubmed/29255512
http://dx.doi.org/10.1016/j.joa.2017.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728996/
https://www.ncbi.nlm.nih.gov/pubmed/29255512
http://dx.doi.org/10.1016/j.joa.2017.08.004

Ejemplares similares